Regal Medical Group, Lakeside Community Healthcare and ADOC Medical Group Add RadNet鈥檚 AI-Powered Enhanced Breast Cancer Detection (EBCD) Program to its Membership Benefits in Southern California
RadNet (NASDAQ:RDNT), a leading outpatient diagnostic imaging services provider, announced that Regal Medical Group, Lakeside Community Healthcare, and ADOC Medical Group will include RadNet's Enhanced Breast Cancer Detection (EBCD) program in their members' health plans.
These medical groups, serving nearly 600,000 members across Southern California, will provide AI-powered breast cancer detection services to all mammogram-eligible patients. RadNet will implement a patient outreach program to boost compliance with annual screening guidelines. The program represents significant progress in securing EBCD reimbursement from commercial payors.
The collaboration aims to improve early breast cancer detection, as one in eight women will develop breast cancer in their lifetime. The AI-powered EBCD program can detect breast cancer earlier than traditional methods, potentially improving patient outcomes through earlier intervention.
RadNet (NASDAQ:RDNT), un importante fornitore di servizi diagnostici di imaging ambulatoriale, ha annunciato che Regal Medical Group, Lakeside Community Healthcare e ADOC Medical Group includeranno il programma Enhanced Breast Cancer Detection (EBCD) di RadNet nei piani sanitari dei loro membri.
Questi gruppi medici, che assistono quasi 600.000 membri nel Sud della California, offriranno servizi di rilevamento del cancro al seno potenziati dall'intelligenza artificiale a tutti i pazienti idonei alla mammografia. RadNet implementer脿 un programma di sensibilizzazione per aumentare l'adesione alle linee guida di screening annuale. Il programma rappresenta un progresso significativo nel garantire il rimborso dell'EBCD da parte dei pagatori commerciali.
La collaborazione mira a migliorare la diagnosi precoce del cancro al seno, dato che una donna su otto svilupper脿 questa malattia nel corso della vita. Il programma EBCD basato sull'IA pu貌 individuare il cancro al seno prima dei metodi tradizionali, migliorando potenzialmente gli esiti per i pazienti grazie a interventi tempestivi.
RadNet (NASDAQ:RDNT), un proveedor l铆der de servicios de diagn贸stico por imagen ambulatorio, anunci贸 que Regal Medical Group, Lakeside Community Healthcare y ADOC Medical Group incluir谩n el programa Enhanced Breast Cancer Detection (EBCD) de RadNet en los planes de salud de sus miembros.
Estos grupos m茅dicos, que atienden a casi 600,000 miembros en el sur de California, ofrecer谩n servicios de detecci贸n de c谩ncer de mama impulsados por inteligencia artificial a todos los pacientes elegibles para mamograf铆as. RadNet implementar谩 un programa de alcance para fomentar el cumplimiento de las pautas de cribado anual. El programa representa un avance significativo para asegurar el reembolso del EBCD por parte de pagadores comerciales.
La colaboraci贸n busca mejorar la detecci贸n temprana del c谩ncer de mama, ya que una de cada ocho mujeres desarrollar谩 c谩ncer de mama a lo largo de su vida. El programa EBCD con IA puede detectar el c谩ncer de mama antes que los m茅todos tradicionales, mejorando potencialmente los resultados para los pacientes mediante una intervenci贸n m谩s temprana.
RadNet (NASDAQ:RDNT)電� 靹犽弰鞝侅澑 鞕鸽灅 歆勲嫧 鞓侅儊 靹滊箘鞀� 鞝滉车鞐呾泊搿滌劀 Regal Medical Group, Lakeside Community Healthcare, ADOC Medical Group鞚� RadNet鞚� 頄レ儊霅� 鞙犽癌鞎� 瓴�於� 頂勲攴鸽灗(EBCD)鞚� 須岇洂 瓯搓皶 氤错棙鞐� 韽暔頃� 瓴冹澊霛缄碃 氚滍憸頄堨姷雼堧嫟.
鞚措摛 鞚橂 攴鸽９鞚� 雮秬 旌橂Μ韽媹鞎� 歆�鞐潣 瓯办潣 60毵� 氇呾潣 須岇洂鞐愱矊 AI 旮半皹 鞙犽癌鞎� 瓴�歆� 靹滊箘鞀るゼ 鞝滉车頃� 鞓堨爼鞛呺媹雼�. RadNet鞚� 鞐瓣皠 瓴�歆� 歆�旃� 欷�靾橂ゼ 雴掛澊旮� 鞙勴暅 頇橃瀽 頇嶋炒 頂勲攴鸽灗鞚� 鞁滍枆頃� 瓴冹瀰雼堧嫟. 鞚� 頂勲攴鸽灗鞚� 靸侅梾 氤错棙靷攵�韯� EBCD 牍勳毄 頇橁笁鞚� 頇曤炒頃橂姅 雿� 欷戩殧頃� 歆勳爠鞚� 鞚橂頃╇媹雼�.
鞚措矆 順戨牓鞚� 鞐劚 8氇� 欷� 1氇�鞚� 韽夓儩 鞙犽癌鞎旍棎 瓯鸽Υ 靾� 鞛堧嫟電� 鞝愳棎靹� 臁瓣赴 鞙犽癌鞎� 氚滉铂鞚� 臧滌劆頃橂姅 瓴冹潉 氇╉憸搿� 頃╇媹雼�. AI 旮半皹 EBCD 頂勲攴鸽灗鞚� 旮办〈 氚╇矔氤措嫟 雿� 鞚检皪 鞙犽癌鞎旍潉 氚滉铂頃� 靾� 鞛堨柎 臁瓣赴 臧滌瀰鞚� 韱淀暣 頇橃瀽 旃橂 瓴瓣臣毳� 頄レ儊鞁滍偓 靾� 鞛堨姷雼堧嫟.
RadNet (NASDAQ:RDNT), un fournisseur leader de services d'imagerie diagnostique ambulatoire, a annonc茅 que Regal Medical Group, Lakeside Community Healthcare et ADOC Medical Group int茅greront le programme Enhanced Breast Cancer Detection (EBCD) de RadNet dans les plans de sant茅 de leurs membres.
Ces groupes m茅dicaux, qui desservent pr猫s de 600 000 membres dans le sud de la Californie, offriront des services de d茅tection du cancer du sein bas茅s sur l'intelligence artificielle 脿 tous les patients 茅ligibles 脿 la mammographie. RadNet mettra en place un programme de sensibilisation des patients pour renforcer le respect des recommandations de d茅pistage annuel. Ce programme constitue une avanc茅e importante pour obtenir le remboursement de l'EBCD par les payeurs commerciaux.
Cette collaboration vise 脿 am茅liorer la d茅tection pr茅coce du cancer du sein, car une femme sur huit d茅veloppera un cancer du sein au cours de sa vie. Le programme EBCD assist茅 par IA peut d茅tecter le cancer du sein plus t么t que les m茅thodes traditionnelles, am茅liorant potentiellement les r茅sultats pour les patients gr芒ce 脿 une intervention plus rapide.
RadNet (NASDAQ:RDNT), ein f眉hrender Anbieter ambulanter diagnostischer Bildgebungsdienste, gab bekannt, dass Regal Medical Group, Lakeside Community Healthcare und ADOC Medical Group das Enhanced Breast Cancer Detection (EBCD)-Programm von RadNet in die Gesundheitspl盲ne ihrer Mitglieder aufnehmen werden.
Diese medizinischen Gruppen, die fast 600.000 Mitglieder in S眉dkalifornien betreuen, werden KI-gest眉tzte Brustkrebserkennungsdienste f眉r alle mammografie-geeigneten Patienten anbieten. RadNet wird ein Patientenanspracheprogramm einf眉hren, um die Einhaltung der j盲hrlichen Screening-Richtlinien zu f枚rdern. Das Programm stellt einen bedeutenden Fortschritt bei der Sicherstellung der Erstattung von EBCD durch kommerzielle Kostentr盲ger dar.
Die Zusammenarbeit zielt darauf ab, die fr眉hzeitige Erkennung von Brustkrebs zu verbessern, da eine von acht Frauen im Laufe ihres Lebens an Brustkrebs erkranken wird. Das KI-gest眉tzte EBCD-Programm kann Brustkrebs fr眉her erkennen als herk枚mmliche Methoden und dadurch potenziell die Behandlungsergebnisse durch fr眉hzeitige Intervention verbessern.
- Expansion of EBCD program coverage to nearly 600,000 Southern California members
- Secured reimbursement agreement with major medical groups, indicating commercial payor traction
- Implementation of proactive patient outreach program to increase screening compliance
- Partnership with one of Southern California's largest physician-owned medical groups
- None.
Insights
RadNet's AI breast cancer detection program gains significant commercial adoption, expanding revenue opportunities and validating its technology in a major healthcare network.
This partnership represents a significant commercial milestone for RadNet's Enhanced Breast Cancer Detection (EBCD) program, securing reimbursement from medical groups affiliated with Heritage Provider Network, which manages nearly 600,000 members across Southern California. The agreement validates RadNet's AI technology in the marketplace and creates a recurring revenue stream through both the EBCD service and the patient outreach program designed to boost screening compliance.
The strategic importance extends beyond immediate revenue. By partnering with these physician-owned medical groups that contract with most major health insurance carriers, RadNet gains exposure to a diverse patient population spanning multiple counties. This positions the company to demonstrate clinical efficacy at scale, potentially accelerating adoption with other commercial payors.
Dr. Berger's statement that these groups will "pave the way for other significant payors to include EBCD in their benefit plans" suggests this is viewed as a catalyst for broader commercial adoption. The agreement also aligns with healthcare's shift toward preventive services and value-based care models that prioritize early detection to reduce downstream costs.
With RadNet's network of 401 imaging centers across eight states, this reimbursement model in Southern California could serve as a template for similar arrangements in other regions. The announcement indicates RadNet is successfully transitioning from technology development to commercial implementation of its AI solutions, with a clear path to scaling this business line through healthcare system partnerships.
- Program will increase access to cutting-edge AI-powered breast cancer detection and is designed to boost compliance with annual cancer-screening guidelines
- Regal Medical Group, Lakeside Community Healthcare and ADOC Medical Group are affiliates of one of Southern California鈥檚 largest health networks, which manages nearly 600,000 members from newborns to Medicare recipients
- Regal Medical Group, Lakeside Community Healthcare and ADOC Medical Group contract with most major health insurance carriers, expanding access to quality care to communities across Southern California
- Program is indicative of EBCD reimbursement traction RadNet is getting with commercial payors
LOS ANGELES, July 09, 2025 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective outpatient diagnostic imaging services, today announced that Regal Medical Group, Lakeside Community Healthcare and ADOC Medical Group, affiliates of Heritage Provider Network (HPN), one of the largest physician-owned medical groups in Southern California, have agreed to reimburse RadNet for its EBCD program -- which will now be included as a benefit in their members鈥� health plans.
These medical groups predominantly located in Los Angeles, Ventura, Orange, San Bernardino, Riverside and San Diego counties, will now provide the AI-powered breast cancer detection services to all of their mammogram-eligible patients. Additionally, RadNet will launch an ongoing patient-outreach program to increase compliance within these medical groups with annual screening guidelines, by proactively contacting eligible patients to encourage and remind them to make their mammography appointments.
Dr. Howard Berger, President and Chief Executive Officer of RadNet, commented, 鈥淩adNet and the Regal, Lakeside and ADOC medical groups share a commitment to early detection of breast cancer and population health screening. One in eight women will develop breast cancer in her lifetime, making it critical to detect the disease early, when treatment options are most optimal. The AI-powered EBCD program is able to detect breast cancer that otherwise would be found much later, thereby improving patient outcomes by reducing the amount of treatment and/or life impact through early detection.鈥�
鈥淲e are excited that Regal Medical Group, Lakeside Community Healthcare and ADOC Medical Group are now offering this program to all of their eligible female patients. We recognize their commitment to provide innovative solutions to their patients, and expect that they will pave the way for other significant payors to include EBCD in their benefit plans,鈥� concluded Dr. Berger.
Will Jukes, Senior Vice President of Regional Operations at Regal Medical Group, added, 鈥淲e continually seek ways to bring leading-edge solutions to patient care. EBCD will increase early cancer detection in addition to traditional radiologist screening, eliminating multiple radiology visits and positively impacting patient outcomes. The collaboration with RadNet will also focus on increasing annual compliance with screening mammography guidelines. Bringing this unique breast cancer screening program to our members is illustrative of our commitment to providing new and leading-edge medicine.鈥�
For media inquiries or further information, please contact:
RadNet, Inc.
Mark Stolper, (310) 445-2800
Executive Vice President and Chief Financial Officer
About Regal Medical Group, Lakeside Community Healthcare and ADOC Medical Group
Regal Medical Group, Lakeside Community Healthcare and ADOC Medical Groups are affiliates of Heritage Provider Network (HPN), which serves as a trusted healthcare network to nearly 600,000 Southern California members. As one of the largest doctor-owned medical groups in Southern California, HPN and its affiliates are dedicated to providing quality, affordable healthcare. For more information, please visit , , or聽
About RadNet, Inc.
RadNet, Inc. is a leading national provider of freestanding, fixed-site diagnostic imaging services in the United States based on the number of locations and annual imaging revenue. RadNet has a network of 401 owned and/or operated outpatient imaging centers. RadNet鈥檚 markets include Arizona, California, Delaware, Florida, Maryland, New Jersey, New York and Texas. In addition, RadNet provides radiology information technology and artificial intelligence solutions marketed under the DeepHealth brand, teleradiology professional services and other related products and services to customers in the diagnostic imaging industry. Together with contracted radiologists, and inclusive of full-time and per diem employees and technologists, RadNet has a total of over 11,000 employees. For more information, visit .
FAQ
What is RadNet's Enhanced Breast Cancer Detection (EBCD) program and how does it work?
Which medical groups are adding RadNet's EBCD program to their benefits?
How many members will have access to RadNet's EBCD program through this partnership?
What impact will RadNet's EBCD program have on breast cancer detection?
How will RadNet (NASDAQ:RDNT) ensure patient participation in the EBCD program?
